About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

17.82 +1.54 (+9.46%)
Streaming Delayed Price Updated: 12:19 PM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Tandem Diabetes (NASDAQ:TNDM) Exceeds Q2 Expectations But Stock Drops 17%
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 8.5% year on year to $240.7 million. The company... 
Via StockStory
News headline image
Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Mixed Q2 2025 Results with Revenue Miss and Wider Loss ↗
Tandem Diabetes Care reported mixed Q2 2025 results with revenue growth but a wider loss, causing a stock drop. Updated guidance reflects R&D costs and operational progress. 
Via Chartmill
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes (TNDM) Q2 Earnings Report Preview: What To Look For
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings this Wednesday after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
1 of Wall Street’s Favorite Stock to Research Further and 2 Facing Headwinds
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5.4% in the morning session after the stock appeared to rebound from a recent 52-week low as investors looked ahead to... 
Via StockStory
Topics Stocks World Trade
News headline image
Marriott Vacations, Wabash, SmartRent, Vestis, and Tandem Diabetes Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. The positive sentiment swept across markets after it was... 
Via StockStory
Topics Stocks World Trade
News headline image
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
News headline image
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
1 Oversold Stock Primed to Rebound and 2 to Ignore
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling... 
Via StockStory
News headline image
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned... 
Via StockStory
Topics ETFs Stocks World Trade
News headline image
3 Small-Cap Stocks with Open Questions
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
Why Tandem Diabetes (TNDM) Shares Are Sliding Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 3.5% in the morning session after a Citi analyst downgraded the stock. Citi analyst Joanna Wuensch downgraded Tandem... 
Via StockStory
Topics Artificial Intelligence
News headline image
Aehr Test Systems Posts Downbeat Sales, Joins RxSight, Vertical Aerospace And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids ↗
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
News headline image
1 Stock Under $50 with Solid Fundamentals and 2 to Ignore
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
1 Growth Stock with All-Star Potential and 2 to Keep Off Your Radar
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued ↗
The agreement is to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with San Diego, California- based Tandem's innovative insulin... 
Via Stocktwits
News headline image
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
News headline image
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges ↗
Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral. 
Via Benzinga
News headline image
Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Tandem Diabetes (NASDAQ:TNDM) and its peers. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.